[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_3973",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_3973"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB06655"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"* Medullary Thyroid Carcinoma VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).     * Hypersensitivity VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or to any of the product components. Serious hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with VICTOZA  [see  Warnings and Precautions 5.6 VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  (4) VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or any of the product components  (4)\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB06655",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-23T19:14:26.265+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "d9Vlfp1Vf1jxuIUpZILvARde79XAv+EnBWP3LJAqM2F1QeU2FO/JoIHztX8vACMkq1yUE/RPp1OQpoiL9WtGwokAvKeg+5xcq1AWXHJlapZvfP6rJmCMXFxpb1AUxK6O9ecjj2uEkXGZp8/8cHE406TVAaYYRWsFrwkYLRqnuFY="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#pubinfo"
} ]